Article
Sequential phenotyping of myeloma patients on chemotherapy: persistence of activated T-cells and natural killer cells.
Leukemia & lymphoma - 1 Jan 1995
Kay N E, Oken M M, Kyle R, Van Ness B, Kalish L, Leong T, Greipp P
Abstract excerpt
To better detail the status of functional T cell subsets and natural killer cells in multiple myeloma, we undertook a detailed immunophenotypic study of circulating mononuclear cells in myeloma. We studied myeloma patients entered on a large prospective, randomized ECOG chemotherapy trial EST 948...
Topics
- Flow Cytometry
- Follow-Up Studies
- Humans
- Immunoglobulin A
- Immunoglobulin G
- Immunophenotyping
- Killer Cells, Natural
- Lymphocyte Activation
- Lymphocyte Subsets
- Lymphocytes
- Multiple Myeloma
- Phenotype
- T-Lymphocytes